The impact of PSA screening on prostate cancer mortality and overdiagnosis of prostate cancer in the United States.

The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
Bret T HowreyJames S Goodwin

Abstract

The study assessed the impact of prostate-specific antigen (PSA) testing in the United States by comparing the rates of PSA testing in U.S. counties to the rates of prostate biopsies and newly treated prostate cancer and to deaths from prostate cancer. We examined the association between the percentage of men aged 66-74 from a nationally representative 5% Medicare sample who received PSA testing in each U.S. county in 1997 and the percent of men who received prostate biopsies or treatment for newly diagnosed prostate cancer in 1997 as well as mortality from prostate cancer and from all other causes from 1998 to 2007. Analyses of 1,067 U.S. counties showed a significant relationship between the rate of PSA testing and both the rate of men undergoing treatment for prostate cancer and prostate cancer mortality (both p < .001) but no relationship with mortality from other causes. For every 100,000 men receiving a PSA test in 1997, an additional 4,894 men underwent prostate biopsy and 1,597 additional men underwent prostate cancer treatment in 1997, and 61 fewer men died from prostate cancer during 1998-2006. Analyses stratified by age and race produced similar results. PSA testing was associated with modest reductions in prostate c...Continue Reading

References

Mar 1, 1981·American Journal of Public Health·C PercyL Gloeckler
Aug 27, 1998·Journal of the National Cancer Institute·A ShibataA S Whittemore
Jun 8, 2001·Journal of the National Cancer Institute·E CrocettiM Zappa
Jun 8, 2001·Journal of the National Cancer Institute·R J Collier, D E Bauman
Dec 6, 2001·Journal of the National Cancer Institute·D F PensonJ L Stanford
Jul 4, 2002·Journal of the National Cancer Institute·Ruth EtzioniEric J Feuer
Jan 14, 2005·The New England Journal of Medicine·Vahakn B ShahinianJames S Goodwin
Jan 13, 2006·Archives of Internal Medicine·John ConcatoPeter Peduzzi
Jun 22, 2006·Journal of the National Cancer Institute·Vahakn B ShahinianJames S Goodwin
Aug 26, 2006·Cancer Causes & Control : CCC·Gary G Schwartz, Carol L Hanchette
Jan 9, 2007·Cancer Causes & Control : CCC·Dragan IlicTimothy Wilt
Jul 16, 2008·BMC Health Services Research·Yong-fang KuoVahakn B Shahinian
Sep 17, 2008·Journal of General Internal Medicine·Grace Lu-YaoMichael J Barry
Dec 5, 2008·Journal of the American Geriatrics Society·Melanie KetchandjiJames S Goodwin
Mar 12, 2009·Journal of the National Cancer Institute·Gerrit DraismaHarry de Koning
Mar 20, 2009·The New England Journal of Medicine·Gerald L AndrioleUNKNOWN PLCO Project Team
Mar 20, 2009·The New England Journal of Medicine·Fritz H SchröderUNKNOWN ERSPC Investigators
Sep 2, 2009·Journal of the National Cancer Institute·H Gilbert Welch, Peter C Albertsen
Sep 2, 2009·Journal of the National Cancer Institute·Otis W Brawley
Jan 7, 2010·British Journal of Cancer·T P KilpeläinenA Auvinen
Mar 5, 2010·CA: a Cancer Journal for Clinicians·Andrew M D WolfUNKNOWN American Cancer Society Prostate Cancer Advisory Committee
Mar 30, 2010·Journal of the American Geriatrics Society·Julie BynumElliott Fisher
Jun 22, 2010·Journal of the National Cancer Institute·Pär StattinUNKNOWN National Prostate Cancer Register (NPCR) of Sweden
Sep 17, 2010·BMJ : British Medical Journal·Mia DjulbegovicPhilipp Dahm
Mar 2, 2011·Journal of the National Cancer Institute·Steven B ZeliadtDaniel W Lin
Dec 29, 2011·JAMA : the Journal of the American Medical Association·Robert J Volk, Andrew M D Wolf
Dec 29, 2011·JAMA : the Journal of the American Medical Association·David C Miller, Brent K Hollenbeck
Mar 16, 2012·The New England Journal of Medicine·Fritz H SchröderUNKNOWN ERSPC Investigators

❮ Previous
Next ❯

Citations

Apr 17, 2013·JAMA Internal Medicine·Louise C WalterRichard M Hoffman
Apr 30, 2015·The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences·Benjamin C TrumbleMichael D Gurven
Dec 3, 2014·Nuclear Medicine and Biology·Tamila J Stott ReynoldsCharles J Smith
May 6, 2014·Journal of the American College of Radiology : JACR·Leonard Berlin
Mar 22, 2014·Journal of Applied Gerontology : the Official Journal of the Southern Gerontological Society·Tetyana Pudrovska, Andriy Anishkin
Aug 3, 2016·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Francisco PinaNuno Lunet
Oct 20, 2018·Frontiers in Genetics·Leire MoyaUNKNOWN Australian Prostate Cancer BioResource
Apr 3, 2019·Journal of Clinical Medicine·Hyun Jun ParkDu Geon Moon
Jan 31, 2019·Diagnostics·Jochen Neuhaus, Bo Yang
Mar 3, 2015·Public Health Reports·Jacques BaillargeonKenneth J Ottenbacher
May 20, 2021·World Journal of Urology·Francisco PinaNuno Lunet

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.